A Study to Evaluate the Safety and Effectiveness of Rivaroxaban (Xarelto) for Prevention of Stroke and Systemic Embolism in Indian Patients With Non-valvular Atrial Fibrillation (NVAF)
Clinical trial NCT03887780 · COMPLETED
Trial details
- NCT number
- NCT03887780
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-10-03
- Primary completion
- 2023-12-23
- Enrollment
- 504
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.